142 related articles for article (PubMed ID: 24467707)
1. Crystal structure of mouse mu-crystallin complexed with NADPH and the T3 thyroid hormone.
Borel F; Hachi I; Palencia A; Gaillard MC; Ferrer JL
FEBS J; 2014 Mar; 281(6):1598-612. PubMed ID: 24467707
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of human micro-crystallin complexed with NADPH.
Cheng Z; Sun L; He J; Gong W
Protein Sci; 2007 Feb; 16(2):329-35. PubMed ID: 17242435
[TBL] [Abstract][Full Text] [Related]
3. µ-Crystallin: A thyroid hormone binding protein.
Kinney CJ; Bloch RJ
Endocr Regul; 2021 May; 55(2):89-102. PubMed ID: 34020530
[TBL] [Abstract][Full Text] [Related]
4. Emerging role of T3-binding protein μ-crystallin (CRYM) in health and disease.
Aksoy O; Hantusch B; Kenner L
Trends Endocrinol Metab; 2022 Dec; 33(12):804-816. PubMed ID: 36344381
[TBL] [Abstract][Full Text] [Related]
5. Insights into Enzyme Catalysis and Thyroid Hormone Regulation of Cerebral Ketimine Reductase/μ-Crystallin Under Physiological Conditions.
Hallen A; Cooper AJ; Jamie JF; Karuso P
Neurochem Res; 2015 Jun; 40(6):1252-66. PubMed ID: 25931162
[TBL] [Abstract][Full Text] [Related]
6. CRYM mutations cause deafness through thyroid hormone binding properties in the fibrocytes of the cochlea.
Oshima A; Suzuki S; Takumi Y; Hashizume K; Abe S; Usami S
J Med Genet; 2006 Jun; 43(6):e25. PubMed ID: 16740909
[TBL] [Abstract][Full Text] [Related]
7. Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancer.
Aksoy O; Pencik J; Hartenbach M; Moazzami AA; Schlederer M; Balber T; Varady A; Philippe C; Baltzer PA; Mazumder B; Whitchurch JB; Roberts CJ; Haitel A; Herac M; Susani M; Mitterhauser M; Marculescu R; Stangl-Kremser J; Hassler MR; Kramer G; Shariat SF; Turner SD; Tichy B; Oppelt J; Pospisilova S; Hartenbach S; Tangermann S; Egger G; Neubauer HA; Moriggl R; Culig Z; Greiner G; Hoermann G; Hacker M; Heery DM; Merkel O; Kenner L
Int J Cancer; 2021 Feb; 148(3):731-747. PubMed ID: 33034050
[TBL] [Abstract][Full Text] [Related]
8. Ketimine reductase/CRYM catalyzes reductive alkylamination of α-keto acids, confirming its function as an imine reductase.
Hallen A; Cooper AJ; Smith JR; Jamie JF; Karuso P
Amino Acids; 2015 Nov; 47(11):2457-61. PubMed ID: 26173510
[TBL] [Abstract][Full Text] [Related]
9. mu-crystallin, a NADPH-dependent T(3)-binding protein in cytosol.
Suzuki S; Mori J; Hashizume K
Trends Endocrinol Metab; 2007 Sep; 18(7):286-9. PubMed ID: 17692531
[TBL] [Abstract][Full Text] [Related]
10. Cytosolic T3-binding protein modulates dynamic alteration of T3-mediated gene expression in cells.
Takeshige K; Sekido T; Kitahara J; Ohkubo Y; Hiwatashi D; Ishii H; Nishio S; Takeda T; Komatsu M; Suzuki S
Endocr J; 2014; 61(6):561-70. PubMed ID: 24646676
[TBL] [Abstract][Full Text] [Related]
11. μ-Crystallin controls muscle function through thyroid hormone action.
Seko D; Ogawa S; Li TS; Taimura A; Ono Y
FASEB J; 2016 May; 30(5):1733-40. PubMed ID: 26718889
[TBL] [Abstract][Full Text] [Related]
12. Mammalian forebrain ketimine reductase identified as μ-crystallin; potential regulation by thyroid hormones.
Hallen A; Cooper AJ; Jamie JF; Haynes PA; Willows RD
J Neurochem; 2011 Aug; 118(3):379-87. PubMed ID: 21332720
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of coenzyme binding to human methionine synthase reductase revealed through the crystal structure of the FNR-like module and isothermal titration calorimetry.
Wolthers KR; Lou X; Toogood HS; Leys D; Scrutton NS
Biochemistry; 2007 Oct; 46(42):11833-44. PubMed ID: 17892308
[TBL] [Abstract][Full Text] [Related]
14. The crystal structure of Escherichia coli ketopantoate reductase with NADP+ bound.
Lobley CM; Ciulli A; Whitney HM; Williams G; Smith AG; Abell C; Blundell TL
Biochemistry; 2005 Jun; 44(25):8930-9. PubMed ID: 15966718
[TBL] [Abstract][Full Text] [Related]
15. micro-Crystallin as an intracellular 3,5,3'-triiodothyronine holder in vivo.
Suzuki S; Suzuki N; Mori J; Oshima A; Usami S; Hashizume K
Mol Endocrinol; 2007 Apr; 21(4):885-94. PubMed ID: 17264173
[TBL] [Abstract][Full Text] [Related]
16. Loss of μ-crystallin causes PPARγ activation and obesity in high-fat diet-fed mice.
Ohkubo Y; Sekido T; Nishio SI; Sekido K; Kitahara J; Suzuki S; Komatsu M
Biochem Biophys Res Commun; 2019 Jan; 508(3):914-920. PubMed ID: 30545633
[TBL] [Abstract][Full Text] [Related]
17. Loss of the thyroid hormone-binding protein Crym renders striatal neurons more vulnerable to mutant huntingtin in Huntington's disease.
Francelle L; Galvan L; Gaillard MC; Guillermier M; Houitte D; Bonvento G; Petit F; Jan C; Dufour N; Hantraye P; Elalouf JM; De Chaldée M; Déglon N; Brouillet E
Hum Mol Genet; 2015 Mar; 24(6):1563-73. PubMed ID: 25398949
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Corticospinal Labeling with mu-crystallin Transgene Reveals Axon Regeneration after Spinal Cord Trauma in ngr1-/- Mice.
Fink KL; Strittmatter SM; Cafferty WB
J Neurosci; 2015 Nov; 35(46):15403-18. PubMed ID: 26586827
[TBL] [Abstract][Full Text] [Related]
19. Letter to the editor: μ-crystallin/CRYM functions as a ketimine-reducing enzyme and plays a role in thyroid hormone bioavailability due to strong inhibition/regulation by thyroid hormones.
Hallen A; Cooper AJ
J Clin Endocrinol Metab; 2015 Jan; 100(1):L15-6. PubMed ID: 25559540
[No Abstract] [Full Text] [Related]
20. Expression of CRYM in different rat organs during development and its decreased expression in degenerating pyramidal tracts in amyotrophic lateral sclerosis.
Hommyo R; Suzuki SO; Abolhassani N; Hamasaki H; Shijo M; Maeda N; Honda H; Nakabeppu Y; Iwaki T
Neuropathology; 2018 Jun; 38(3):247-259. PubMed ID: 29603402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
